Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the Low Risk Penny Stocks to Buy Now. On February 27, Bank of America ...

It's good to see everybody, and welcome back to TD Cowen's 46th Annual Healthcare Conference. It is my pleasure to be joined today by Recursion's CFO, Ben Taylor. We've got a lot of great stuff to ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

As the program engages more directly with global concerns such as the climate crisis, he will lead the way.

"If you love trains, you understand the big difference between knowing a train is due soon and actually seeing the massive ...

By Joseph Tulloch For years, AI safety experts have been warning of a future moment where AI models become advanced enough to ...

T-cell engager (TCE) specialist Candid Therapeutics has entered into a reverse merger agreement with Rallybio that will allow ...

AI development is often framed as a race among countries, companies and academic researchers. But figuring out who’s actually ...

Oracle-based quantum algorithms cannot use deep loops because quantum states exist only as mathematical amplitudes in Hilbert space with no physical substrate. Criticall ...

By now, you’ve perhaps heard of looksmaxxers, the young men pursuing extreme physical transformation in the belief that appearance is the sole determinant of social and sexual success. If not, I’m ...

Those that solve artificially simplified problems where quantum advantage is meaningless. Those that provide no genuine quantum advantage when all costs are properly accounted for. This critique is ...

Thank you to everyone who hosted watch parties and celebrated National Chemistry Week 2025 with us! If you were unable to attend live, ACS invites you to use the recording of this year's event ...